Myrophine

Myrophine

File:Myrophine.svg
Gene therapy
Clinical data
Other names	Myrophine, Myristylbenzylmorphine
Physiological data
Legal status
Legal status	US: Schedule I
Pharmacokinetic data
Identifiers
IUPAC name 7,8-didehydro-4,5α-epoxy-17-methyl-3-(phenylmethoxy)-morphinan-6-ol tetradecanoate
CAS Number	467-18-5
PubChem Template:Abbreviation	635600
Chemical and physical data
Formula	C38H51NO4
Molar mass	585.82 g/mol

Myrophine (Myristylbenzylmorphine) is an opiate analogue that is a derivative of morphine.

Myrophine is substituted with a 3-benzyl group and a 6-myristyl chain. It is metabolised to form benzylmorphine and then further to morphine, and so is a long-acting prodrug for morphine, but with a slow onset of effects. It is a Schedule I drug in the USA and is controlled under international drug conventions.

References

Template:Opioids